Nurse Anesthetist - CR in Grand Junction, CO Accepting Medicare
3 Nurse Anesthetist - CR nurses found. Showing 1 - 3
 Mr. John Earl Taylor, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731 |
Mr. Michael Bradley Buxton, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731 |
Christopher G Mroz, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731 Fax: 970-263-5003 |
News Archive
Majority of U.S. House supports repeal of Medicare therapy caps
With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.
CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).
Obese patients tend to require additional ICU services after heart surgery
After heart surgery, obese patients tend to require additional intensive care unit (ICU) services and longer recovery times when compared to non-obese patients. This results in more expensive, more labor-intensive care, according to a study published online today in The Annals of Thoracic Surgery.
ReCor completes enrollment in PARADISE system clinical study for 'resistant' hypertension
ReCor Medical, an emerging medical device company, announced today that it has completed enrollment in the REDUCE 15-patient pilot clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
› Verified 7 days ago